tirzepatide vs saxenda Wegovy | Weight-loss injections Tirzepatide vs Semaglutide: A Comprehensive

Unlike other injectables that act on just one hormone, Tirzepatide activates both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors

NICE guideline NG136 (Hypertension in adults: diagnosis and management) recommends a stepwise approach

doi:10.1186/s12933-023-01765-z 2.Y

Most clinical trials on semaglutide focus on blood sugar control, weight loss, and digestive side effects rather than urination patterns

Prescription GLP-1 receptor agonists, like Wegovy and Zepbound, work by directly mimicking this hormone and activating GLP-1 receptors in the body

Tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it activates two hormonal pathways involved in appetite regulation and glucose metabolism